Brought to you by 
Astute Medical raises $26.5mm through its Series B round; adds $13mm
28 Mar 2011
Executive Summary
Astute Medical Inc. (rapid diagnostics for high-risk medical conditions) has raised $26.5mm through the closing of its Series B venture round. Domain Associates and Delphi Ventures led and were joined by Johnson & Johnson Development Corp. and current shareholder De Novo Ventures.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Astute Medical raises $26.5mm through its Series B round; adds $13mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice